Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age
Author:
Affiliation:
1. University of Utah School of Medicine Salt Lake City Utah USA
2. 21st Century Oncology Uro‐Medix/GenesisCare Aventura Florida USA
3. Antares Pharma, Inc. Ewing New Jersey USA
4. Men's Health Center Miriam Hospital Providence Rhode Island USA
Publisher
Wiley
Subject
Urology,Endocrinology,Reproductive Medicine,Endocrinology, Diabetes and Metabolism
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/andr.13108
Reference99 articles.
1. US Food and Drug Administration.FDA Drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use.2018. Accessed February 9 2020.https://www.fda.gov/drugs/drug‐safety‐and‐availability/fda‐drug‐safety‐communication‐fda‐cautions‐about‐using‐testosterone‐products‐low‐testosterone‐due.
2. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
3. Evaluation and Management of Testosterone Deficiency: AUA Guideline
4. Critical evaluation of different available guidelines for late‐onset hypogonadism
5. Loss of Circadian Rhythmicity in Blood Testosterone Levels with Aging in Normal Men*
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism;Andrology;2024-09-10
2. Age‐related impairment in testosterone elevation after anterior fibromuscular stroma preserved enucleation;International Journal of Urology;2024-07-15
3. Testosterone concentrations and associated predictors in men with cystic fibrosis: A retrospective, single-center study;The American Journal of the Medical Sciences;2024-07
4. Falsely elevated serum testosterone measurements resulting from testosterone topical gel contamination of the venipuncture site: Case Series and retrospective review;Heliyon;2023-12
5. Conclusion: Resistance: The Way Forward;Trans Athletes’ Resistance;2023-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3